An update on the new classification of Ehlers-Danlos syndrome and review of the causes of bleeding in this population

被引:24
作者
Jesudas, Rohith [1 ]
Chaudhury, Ateefa [2 ]
Laukaitis, Christina M. [3 ,4 ]
机构
[1] Bleeding & Clotting Disorders Inst, 9128 N Lindbergh Dr, Peoria, IL 61615 USA
[2] Ctr Inherited Blood Disorders, Orange, CA USA
[3] Univ Arizona, Coll Med, Dept Med, Tucson, AZ USA
[4] Univ Arizona, Coll Med, Dept Nutr, Tucson, AZ USA
关键词
bleeding disorder; Ehlers-Danlos Syndrome; generalized joint hypermobility; hEDS; mast cell activation disorder; VON-WILLEBRAND-FACTOR; JOINT HYPERMOBILITY SYNDROME; VASCULAR-TYPE; PLATELET ACTIVATION; CLOTTING DISORDERS; GLYCOPROTEIN-VI; COLLAGEN; BINDING; ABNORMALITIES; HEMOSTASIS;
D O I
10.1111/hae.13800
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has long been hypothesized that bleeding symptoms in people with hypermobility occur as a result of abnormalities in the collagen of the vessel wall or the connective tissues. The bleeding symptoms, particularly in the skin, have been attributed to the fragility of skin and blood vessels caused by "defective collagen wickerwork" of the reticular layer of the skin. Collagen, which forms the framework of vessel walls, is altered in many patients with Ehlers-Danlos syndrome (EDS) leading to weakening of the vessel wall or the supporting tissues. Another important function of subendothelial collagen is its interaction with platelets and von Willebrand factor, which results in the propagation of a platelet plug. Thus, abnormalities in subendothelial collagen may alter its interaction with platelets and VWF. More recently, hypermobile-EDS (hEDS) has been associated with mast cell disorders, a condition independently associated with bleeding symptoms. It has also been observed that patients with mild bleeding disorders have a more severe bleeding phenotype when they have co-existing joint hypermobility.
引用
收藏
页码:558 / 566
页数:9
相关论文
共 60 条
[1]   PLATELET AND COAGULATION STUDIES IN EHLERS-DANLOS SYNDROME [J].
ANSTEY, A ;
MAYNE, K ;
WINTER, M ;
VANDEPETTE, J ;
POPE, FM .
BRITISH JOURNAL OF DERMATOLOGY, 1991, 125 (02) :155-163
[2]   PLATELETS WITH 10-PERCENT OF THE NORMAL AMOUNT OF GLYCOPROTEIN-VI HAVE AN IMPAIRED RESPONSE TO COLLAGEN THAT RESULTS IN A MILD BLEEDING TENDENCY [J].
ARAI, M ;
YAMAMOTO, N ;
MOROI, M ;
AKAMATSU, N ;
FUKUTAKE, K ;
TANOUE, K .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (01) :124-130
[3]   Application of immunotherapy for neurological manifestations in hypermobile Ehlers-Danlos syndrome [J].
Araki, Manabu ;
Lin, Youwei ;
Ono, Hirohiko ;
Sato, Wakiro ;
Yamamura, Takashi .
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
[4]   Hemostatic abnormalities in patients with Ehlers-Danlos syndrome [J].
Artoni, A. ;
Bassotti, A. ;
Abbattista, M. ;
Marinelli, B. ;
Lecchi, A. ;
Gianniello, F. ;
Clerici, M. ;
Bucciarelli, P. ;
La Marca, S. ;
Peyvandi, F. ;
Martinelli, I. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (12) :2425-2431
[5]   Pharmacological resources, diagnostic approach and coordination of care in joint hypermobility-related disorders [J].
Baban, Anwar ;
Castori, Marco .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (07) :689-703
[6]  
Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO
[7]  
2-P
[8]   EHLERS-DANLOS SYNDROME, CLOTTING DISORDERS AND MUSCULAR-DYSTROPHY [J].
BERTIN, P ;
TREVES, R ;
JULIA, A ;
GAILLARD, S ;
DESPROGESGOTTERON, R .
ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (11) :953-956
[9]   Ehlers-Danlos Syndrome, Classical Type [J].
Bowen, Jessica M. ;
Sobey, Glenda J. ;
Burrows, Nigel P. ;
Colombi, Marina ;
Lavallee, Mark E. ;
Malfait, Fransiska ;
Francomano, Clair A. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2017, 175 (01) :27-39
[10]   EHLERS-DANLOS SYNDROME - A REPORT OF 4 CASES IN 2 GENERATIONS OF A NEGRO FAMILY [J].
BRUNO, MS ;
NARASIMHAN, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1961, 264 (06) :274-&